These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 4784627

  • 1. Erythropoiesis and erythropoietin in busulphan treated mice.
    Barrio Rendo ME, Alvarez Prado de Tombol, Scaro JL.
    Acta Physiol Lat Am; 1973; 23(5):327-33. PubMed ID: 4784627
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of electrical stimulation of the hypothalamus on red cell production and destruction in the rat.
    Segal R, Izak G, Feldman S.
    Isr J Med Sci; 1971; 7(7):1017-24. PubMed ID: 4329104
    [No Abstract] [Full Text] [Related]

  • 6. [The erythropoiesis inhibitor and erythropoietin].
    Krzymowska H, Krzymowski T, Iwańska S, Dusza L.
    Acta Physiol Pol; 1971; 22(6):803-9. PubMed ID: 5152816
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of plethora on the erythropoietic response of the bone marrow to exogenous erythropoietin in the mouse.
    Bozzini CE, Alippi RM.
    Acta Physiol Lat Am; 1971; 21(3):198-202. PubMed ID: 5158676
    [No Abstract] [Full Text] [Related]

  • 9. beta 2-Adrenergic stimulation of erythropoiesis in busulfan treated mice.
    Jelkmann W, Bauer C.
    Exp Hematol; 1980 Jul; 8(6):742-8. PubMed ID: 7202579
    [Abstract] [Full Text] [Related]

  • 10. Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocrit.
    Andrews DA, Boren BM, Turk JR, Boyce RW, He YD, Hamadeh HK, Mytych DT, Barger TE, Salimi-Moosavi H, Sloey B, Elliott S, McElroy P, Sinclair AM, Shimamoto G, Pyrah IT, Lightfoot-Dunn RM.
    Toxicol Pathol; 2014 Jul; 42(3):524-39. PubMed ID: 23674391
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preliminary purification and dosages of the erythropoietic factor from ox-spleen.
    de Franciscis P, Greco AM, Bertuglia S, Nastasi A.
    Experientia; 1975 Oct 15; 31(10):1221-3. PubMed ID: 1204750
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M.
    Exp Hematol; 1993 Apr 15; 21(4):496-501. PubMed ID: 8462658
    [Abstract] [Full Text] [Related]

  • 15. Erythroid differentiation during stem cell proliferation.
    DeGowin RL.
    J Lab Clin Med; 1967 Jul 15; 70(1):23-35. PubMed ID: 6027095
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Suppressive effect of acetylsalicylic acid on erythropoietin-responsive cells in mice.
    Giglio MJ, Santoro RC, Bozzini CE.
    Acta Physiol Pharmacol Latinoam; 1984 Jul 15; 34(3):229-34. PubMed ID: 6241781
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.